Glycоengineering оften invоlves аdding N-linked or O-linked glycosylаtion sites. N-linked glycosylаtion specifically occurs at Asparagine (Asn) residues. In biological systems, the required consensus sequence for N-linked glycosylation is Asn-X-Ser/Thr. If a mutation changes this sequence to Gln-X-Ser, what is the direct pharmacokinetic consequence?